Human adipose tissue-derived SSEA-4 subpopulation multi-differentiation potential towards the endothelial and osteogenic lineages

Human adipose tissue has been recently recognized as a potential source of stem cells for regenerative medicine applications, including bone tissue engineering (TE). Despite the gathered knowledge regarding the differentiation potential of human adipose tissue-derived stem cells (hASCs), in what con...

Full description

Saved in:
Bibliographic Details
Published in:Tissue engineering. Part A Vol. 19; no. 1-2; p. 235
Main Authors: Mihaila, Silvia M, Frias, Ana M, Pirraco, Rogério P, Rada, Tommaso, Reis, Rui L, Gomes, Manuela E, Marques, Alexandra P
Format: Journal Article
Language:English
Published: United States 01-01-2013
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Human adipose tissue has been recently recognized as a potential source of stem cells for regenerative medicine applications, including bone tissue engineering (TE). Despite the gathered knowledge regarding the differentiation potential of human adipose tissue-derived stem cells (hASCs), in what concerns the endothelial lineage many uncertainties are still present. The existence of a cell subpopulation within the human adipose tissue that expresses a SSEA-4 marker, usually associated to pluripotency, raises expectations on the differentiation capacity of these cells (SSEA-4(+)hASCs). In the present study, the endothelial and osteogenic differentiation potential of the SSEA-4(+)hASCs was analyzed, aiming at proposing a single-cell source/subpopulation for the development of vascularized bone TE constructs. SSEA-4(+)hASCs were isolated using immunomagnetic sorting and cultured either in α-MEM, in EGM-2 MV (endothelial growth medium), or in osteogenic medium. SSEA-4(+)hASCs cultured in EGM-2 MV formed endothelial cell-like colonies characterized by a cobblestone morphology and expression of CD31, CD34, CD105, and von Willebrand factor as determined by quantitative reverse transcriptase (RT)-polymerase chain reaction, immunofluorescence, and flow cytometry. The endothelial phenotype was also confirmed by their ability to incorporate acetylated low-density lipoprotein and to form capillary-like structures when seeded on Matrigel. SSEA-4(+)hASCs cultured in α-MEM displayed fibroblastic-like morphology and exhibited a mesenchymal surface marker profile (>90% CD90(+)/CD73(+)/CD105(+)). After culture in osteogenic conditions, an overexpression of osteogenic-related markers (osteopontin and osteocalcin) was observed both at molecular and protein levels. Matrix mineralization detected by Alizarin Red staining confirmed SSEA-4(+)hASCs osteogenic differentiation. Herein, we demonstrate that from a single-cell source, human adipose tissue, and by selecting the appropriate subpopulation it is possible to obtain microvascular-like endothelial cells and osteoblasts, the most relevant cell types for the creation of vascularized bone tissue-engineered constructs.
AbstractList Human adipose tissue has been recently recognized as a potential source of stem cells for regenerative medicine applications, including bone tissue engineering (TE). Despite the gathered knowledge regarding the differentiation potential of human adipose tissue-derived stem cells (hASCs), in what concerns the endothelial lineage many uncertainties are still present. The existence of a cell subpopulation within the human adipose tissue that expresses a SSEA-4 marker, usually associated to pluripotency, raises expectations on the differentiation capacity of these cells (SSEA-4(+)hASCs). In the present study, the endothelial and osteogenic differentiation potential of the SSEA-4(+)hASCs was analyzed, aiming at proposing a single-cell source/subpopulation for the development of vascularized bone TE constructs. SSEA-4(+)hASCs were isolated using immunomagnetic sorting and cultured either in α-MEM, in EGM-2 MV (endothelial growth medium), or in osteogenic medium. SSEA-4(+)hASCs cultured in EGM-2 MV formed endothelial cell-like colonies characterized by a cobblestone morphology and expression of CD31, CD34, CD105, and von Willebrand factor as determined by quantitative reverse transcriptase (RT)-polymerase chain reaction, immunofluorescence, and flow cytometry. The endothelial phenotype was also confirmed by their ability to incorporate acetylated low-density lipoprotein and to form capillary-like structures when seeded on Matrigel. SSEA-4(+)hASCs cultured in α-MEM displayed fibroblastic-like morphology and exhibited a mesenchymal surface marker profile (>90% CD90(+)/CD73(+)/CD105(+)). After culture in osteogenic conditions, an overexpression of osteogenic-related markers (osteopontin and osteocalcin) was observed both at molecular and protein levels. Matrix mineralization detected by Alizarin Red staining confirmed SSEA-4(+)hASCs osteogenic differentiation. Herein, we demonstrate that from a single-cell source, human adipose tissue, and by selecting the appropriate subpopulation it is possible to obtain microvascular-like endothelial cells and osteoblasts, the most relevant cell types for the creation of vascularized bone tissue-engineered constructs.
Author Rada, Tommaso
Gomes, Manuela E
Marques, Alexandra P
Pirraco, Rogério P
Mihaila, Silvia M
Frias, Ana M
Reis, Rui L
Author_xml – sequence: 1
  givenname: Silvia M
  surname: Mihaila
  fullname: Mihaila, Silvia M
  organization: Department of Polymer Engineering, 3B's Research Group, University of Minho, Guimarães, Portugal
– sequence: 2
  givenname: Ana M
  surname: Frias
  fullname: Frias, Ana M
– sequence: 3
  givenname: Rogério P
  surname: Pirraco
  fullname: Pirraco, Rogério P
– sequence: 4
  givenname: Tommaso
  surname: Rada
  fullname: Rada, Tommaso
– sequence: 5
  givenname: Rui L
  surname: Reis
  fullname: Reis, Rui L
– sequence: 6
  givenname: Manuela E
  surname: Gomes
  fullname: Gomes, Manuela E
– sequence: 7
  givenname: Alexandra P
  surname: Marques
  fullname: Marques, Alexandra P
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22924692$$D View this record in MEDLINE/PubMed
BookMark eNo1kL1OwzAYRS0EoqXwACzIL-Dgv8T1WFWFIlViKEhslWN_KUaJHcUOiJE3p1CYju4Z7nAu0GmIARC6ZrRgdK5vM4Qigyk4ZbygVPMTNGVaKCJE-TJBFym9UVrRSqlzNOFcc1lpPkVf67EzARvn-5gAZ5_SCMTB4N_B4e12tSASp7HuYz-2JvsYcDe22RPnmwYGCNkfbR_z72hxjh9mcAnnV8AQXDyw_fEmOBxThriH4C1ufQCzh3SJzhrTJrj64ww9362elmuyebx_WC42xJZCZOKs5lxZPWfC8Fopw5jkVAsLjXJlzcq5qritTekaW4taOsHEIYyUTirHreQzdHP87ce6A7frB9-Z4XP334J_AzcTZVU
CitedBy_id crossref_primary_10_1007_s12033_013_9702_4
crossref_primary_10_2217_rme_14_72
crossref_primary_10_1007_s40883_017_0029_8
crossref_primary_10_1371_journal_pone_0095583
crossref_primary_10_1002_term_2495
crossref_primary_10_3390_ijms21041408
crossref_primary_10_1088_1748_605X_aac78b
crossref_primary_10_1002_term_2096
crossref_primary_10_1016_j_biomaterials_2014_07_052
crossref_primary_10_1089_ten_tea_2013_0273
crossref_primary_10_1002_jbm_a_34614
crossref_primary_10_1021_bm500036a
crossref_primary_10_1155_2023_1842958
crossref_primary_10_1016_j_actbio_2016_05_033
crossref_primary_10_1016_j_actbio_2017_09_014
crossref_primary_10_1111_cpr_12493
crossref_primary_10_1016_j_nano_2017_04_016
crossref_primary_10_1155_2016_3187491
crossref_primary_10_1016_j_ijscr_2022_107861
crossref_primary_10_1089_ten_tea_2013_0740
crossref_primary_10_4252_wjsc_v6_i3_256
crossref_primary_10_1155_2022_1309684
crossref_primary_10_1016_j_biomaterials_2014_11_047
crossref_primary_10_1186_s13287_022_02928_7
crossref_primary_10_1080_23808993_2016_1140004
crossref_primary_10_1038_srep16681
crossref_primary_10_3390_biom12091317
crossref_primary_10_1016_j_addr_2022_114299
crossref_primary_10_1155_2015_350718
crossref_primary_10_1134_S1062360415020058
crossref_primary_10_1038_s12276_022_00839_4
crossref_primary_10_3390_cells10020218
crossref_primary_10_1002_term_2967
crossref_primary_10_1097_SAP_0000000000000704
crossref_primary_10_1016_j_arthro_2013_12_009
crossref_primary_10_3390_cells9051097
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1089/ten.tea.2012.0092
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Engineering
EISSN 1937-335X
ExternalDocumentID 22924692
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
1-M
123
29Q
3V.
4.4
53G
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
ABBKN
ABUWG
ACGFO
ACGOD
ACPRK
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CS3
CUY
CVF
DU5
DWQXO
EBS
ECM
EIF
EJD
F5P
FYUFA
GNUQQ
HCIFZ
HMCUK
IAO
IER
IGS
IHR
ITC
LK8
M0L
M1P
M2P
M7P
MV1
NPM
NQHIM
O9-
PQQKQ
PROAC
PSQYO
RML
RNS
UE5
UKHRP
ID FETCH-LOGICAL-c533t-dc9227c9813a2b77a1142093cef7d5b158762cba5dfcb3b4d31310844d47d2c42
IngestDate Sat Sep 28 08:04:16 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1-2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c533t-dc9227c9813a2b77a1142093cef7d5b158762cba5dfcb3b4d31310844d47d2c42
OpenAccessLink http://hdl.handle.net/1822/23722
PMID 22924692
ParticipantIDs pubmed_primary_22924692
PublicationCentury 2000
PublicationDate 2013-01-01
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – month: 01
  year: 2013
  text: 2013-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Tissue engineering. Part A
PublicationTitleAlternate Tissue Eng Part A
PublicationYear 2013
References 20058201 - Stem Cell Rev. 2009 Dec;5(4):378-86
15641985 - J Oral Pathol Med. 2005 Feb;34(2):70-6
12009786 - Exp Mol Pathol. 2002 Jun;72(3):221-9
19111010 - J Tissue Eng Regen Med. 2009 Feb;3(2):158-9
11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45
17525234 - Stem Cells. 2007 Sep;25(9):2269-76
18393893 - Curr Top Med Chem. 2008;8(4):300-10
12757882 - Cardiovasc Res. 2003 May 1;58(2):478-86
16798864 - J Dent Res. 2006 Jul;85(7):633-7
19508152 - Stem Cells Dev. 2009 Nov;18(9):1299-308
17928113 - Clin Biomech (Bristol, Avon). 2008;23 Suppl 1:S118-24
15153613 - Stem Cells. 2004;22(3):367-76
15880450 - J Cell Physiol. 2005 Oct;205(1):114-22
15639471 - Cardiovasc Res. 2005 Feb 1;65(2):328-33
11081514 - Nature. 2000 Nov 2;408(6808):92-6
15661340 - Trends Biotechnol. 2005 Feb;23(2):64-6
20396979 - Stem Cell Rev. 2011 Mar;7(1):64-76
9129027 - Blood. 1997 May 1;89(9):3228-35
12609567 - Lung Cancer. 2003 Mar;39(3):289-96
19375653 - Exp Hematol. 2009 May;37(5):629-40
9576104 - Circ Res. 1998 May 4;82(8):845-51
16263424 - Exp Hematol. 2005 Nov;33(11):1402-16
18770637 - Curr Protoc Stem Cell Biol. 2008 Jul;Chapter 2:Unit 2C.1
4355998 - J Clin Invest. 1973 Nov;52(11):2745-56
12475952 - Mol Biol Cell. 2002 Dec;13(12):4279-95
17974012 - J Transl Med. 2007;5:55
9020076 - Science. 1997 Feb 14;275(5302):964-7
18564036 - Stem Cells Dev. 2008 Oct;17(5):909-16
14656930 - Circ Res. 2004 Feb 6;94(2):223-9
1693532 - Blood. 1990 Jun 15;75(12):2417-26
17095706 - Stem Cells. 2007 Mar;25(3):750-60
17569886 - Circ Res. 2007 Aug 3;101(3):286-94
9811868 - Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13726-31
15389528 - J Cell Physiol. 2005 Jan;202(1):41-8
18819086 - Curr Protoc Stem Cell Biol. 2008 Sep;Chapter 1:Unit 1F.5
16386732 - Exp Cell Res. 2006 Apr 1;312(6):727-36
11407479 - Virchows Arch. 2001 May;438(5):498-504
15004192 - J Immunol. 2004 Mar 15;172(6):3850-9
12110702 - Stem Cells. 2002;20(4):329-37
17518736 - Tissue Eng. 2007 Aug;13(8):1799-808
15965465 - Nat Biotechnol. 2005 Jul;23(7):879-84
18454639 - Tissue Eng Part B Rev. 2008 Mar;14(1):133-47
19852056 - Cytometry A. 2010 Jan;77(1):22-30
12027467 - Eur J Vasc Endovasc Surg. 2002 May;23(5):404-12
15153614 - Stem Cells. 2004;22(3):377-84
11304456 - Tissue Eng. 2001 Apr;7(2):211-28
15238461 - Circulation. 2004 Jul 20;110(3):349-55
11069627 - J Invest Dermatol. 2000 Nov;115(5):882-8
19880177 - Biomaterials. 2010 Feb;31(6):1171-9
17495232 - Circ Res. 2007 May 11;100(9):1249-60
20865694 - J Tissue Eng Regen Med. 2011 Apr;5(4):e52-62
18534784 - Pathol Biol (Paris). 2009 Jun;57(4):309-17
19883577 - J Surg Res. 2009 Mar;152(1):157-66
15694406 - Biochem Biophys Res Commun. 2005 Mar 18;328(3):721-7
12837583 - Trends Cardiovasc Med. 2003 Jul;13(5):201-6
17421060 - J Gene Med. 2007 Jun;9(6):452-61
12835573 - Cells Tissues Organs. 2003;174(3):101-9
16003365 - Nat Biotechnol. 2005 Jul;23(7):821-3
11722432 - Br J Haematol. 2001 Oct;115(1):186-94
References_xml
SSID ssj0060677
Score 2.272167
Snippet Human adipose tissue has been recently recognized as a potential source of stem cells for regenerative medicine applications, including bone tissue engineering...
SourceID pubmed
SourceType Index Database
StartPage 235
SubjectTerms Adipocytes - cytology
Adipocytes - metabolism
Blood Vessels - cytology
Blood Vessels - growth & development
Cell Differentiation
Cells, Cultured
Endothelial Cells - cytology
Endothelial Cells - physiology
Female
Humans
Middle Aged
Osteoblasts - cytology
Osteoblasts - physiology
Osteogenesis - physiology
Stage-Specific Embryonic Antigens - metabolism
Tissue Engineering - methods
Title Human adipose tissue-derived SSEA-4 subpopulation multi-differentiation potential towards the endothelial and osteogenic lineages
URI https://www.ncbi.nlm.nih.gov/pubmed/22924692
Volume 19
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV07b9swECbsdmmHou93waGbwdSiKJEcg9RBlhRF7QLZAoqUWgK2JFhK9v7zHkm9nLRAOnQRbBJ6gPfp-JG6-w6hj0yLRIOfI6rQS8JggiJCpIIooaVYcpprr1NwtuZfLsTnFVvNZn1117Htv1oa2sDWLnP2H6w9XBQa4DfYHI5gdTjeye5hV14ZW7tI9NaPKzFw52tHLderY8IWzVVWD4W7Qkwh6SultMFWi7pq_Z8tsFMXWduE8I_SuJStre0kBlyKSAXPYvXC8VVwTs2U7m787eGsQfTwCDjrvh13UM_tT2W3nsGu7fbaqnF79hRGK9RKLietX-1-D148RIX_CN_597Ya89S-KeMvt6l2O9VU020NV2Ji2NbIgysG4kTiOLk48NVyiskucbJzvUH25NaUsBROURWG7AjeGhfL5xRaQ_29CRzqnccDpbAeTe_Se0Olu--aozlwLkfLT857RpA6lb7-i7qQn249i1Ok7s6_sbrxLGfzGD3qlif4OODqCZrl5VP0cCJa-Qz98gjDHcLwIcJwQBg-QBj-I8LwgDDcIQwDsvAEYRgQhkeE4R5hz9H309Xm5Ix0hTyIhtVES4yWlHJ4-aNY0Yxz5RK4lzLWecFNkkWJm5J1phJT6CzOmIkjWHUIxgzjhoIreYHulVWZv0JYUxPlQqayyDVjiotUmUKySApdcJqa1-hlGL_LOqi1XPYj--avPW_RgxGB79D9AlxB_h7NG3P1wRvyN5U8hHk
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+adipose+tissue-derived+SSEA-4+subpopulation+multi-differentiation+potential+towards+the+endothelial+and+osteogenic+lineages&rft.jtitle=Tissue+engineering.+Part+A&rft.au=Mihaila%2C+Silvia+M&rft.au=Frias%2C+Ana+M&rft.au=Pirraco%2C+Rog%C3%A9rio+P&rft.au=Rada%2C+Tommaso&rft.date=2013-01-01&rft.eissn=1937-335X&rft.volume=19&rft.issue=1-2&rft.spage=235&rft_id=info:doi/10.1089%2Ften.tea.2012.0092&rft_id=info%3Apmid%2F22924692&rft_id=info%3Apmid%2F22924692&rft.externalDocID=22924692